Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2018

Nov 21, 2018

33298_dirs_2018-11-21_e9cc5ebc-6324-483c-9101-367a6ceb6209.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2018-11-20

Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-20 Common Stock, par value $0.01 P 1500 $0.1487 Acquired 2971693 Indirect
2018-11-20 Common Stock, par value $0.01 P 4900 $0.1698 Acquired 2976593 Indirect
2018-11-20 Common Stock, par value $0.01 P 14206 $0.15 Acquired 2990799 Indirect
2018-11-20 Common Stock, par value $0.01 P 8250 $0.172 Acquired 2999049 Indirect
2018-11-20 Common Stock, par value $0.01 P 1750 $0.1708 Acquired 3000799 Indirect
2018-11-20 Common Stock, par value $0.01 P 20000 $0.17 Acquired 3020799 Indirect

Footnotes

F1: These shares were purchased on the open market.